Benefits Improves blood sugar control in type 2 diabetes May support clinically significant weight loss Convenient once-weekly dosing Lowers risk of cardiovascular events in eligible patients Reduces appetite and promotes healthy eating habits How to Take Inject once a week, on the same day each week Use exactly as prescribed by your healthcare provider Rotate injection sites (abdomen, thigh, or upper arm) Start at 0.25mg, increasing gradually to the maintenance dose (usually 1mg) Side Effects Common: Nausea, vomiting, diarrhoea, constipation, indigestion Less common: Headache, dizziness, fatigue Rare but serious: Pancreatitis seek immediate medical help for severe abdominal pain Cautions Prescription-only medication Not suitable for type 1 diabetes or diabetic ketoacidosis Avoid if allergic to semaglutide or any pen components Not recommended during pregnancy or breastfeeding unless advised by a specialist FAQs Q1: What is Ozempic used for

Orforglipron enables oral GLP-1 receptor activation through a non-peptide, small-molecule architecture that avoids the inherent instability of peptide agonists
True non-responders: uncertain outcomes If semaglutide produced absolutely no appetite suppression, no metabolic improvement, and no weight loss even at the maximum 2.4mg dose over 16 or more weeks, you may have fundamental resistance to GLP-1 receptor agonism
It takes 4-5 half lives for a medication to be fully cleared
A linear peptide samples an enormous number of conformations in solution, and only a small fraction resemble the shape a receptor binds
All those experts voted in favor of allowing specialty pharmacies to produce their own formulations of BPC-157 for patients